ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company developing, manufacturing, and commercializing innovative and high-quality therapeutics as we transform into a leading Rare Disease company.
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
2026-04-20
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
2026-04-13
$80.96
+0.04 ( 0.05% )
Pricing delayed by 20 minutes
Last updated
2026-04-20 09:33:00